BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 35598153)

  • 1. Analysis of prognostic factors in Grade 3 endometrioid type endometrial carcinoma.
    Sahin EA; Toprak S; Sayal HB; Ekinci T; Yılmaz E; Bakay K; Melekoğlu R; Sezgin B; Tohma YA; Şahin H
    Int J Gynaecol Obstet; 2022 Dec; 159(3):719-726. PubMed ID: 35598153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between lymphovascular space invasion, nodal recurrence, and survival in patients with surgical stage I endometrioid endometrial adenocarcinoma.
    Veade AE; Foote J; Ehrisman J; Broadwater G; Davidson BA; Lee PS; Secord AA; Berchuck A; Havrilesky LJ
    World J Surg Oncol; 2019 May; 17(1):80. PubMed ID: 31077193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrence patterns and prognostic factors in lymphovascular space invasion-positive endometrioid endometrial cancer surgically confined to the uterus.
    Sahin H; Meydanli MM; Sari ME; Kocaman E; Cuylan ZF; Yalcin I; Coban G; Özen Ö; Sirvan L; Güngör T; Ayhan A
    Taiwan J Obstet Gynecol; 2019 Jan; 58(1):82-89. PubMed ID: 30638487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors and patterns of recurrence in lymphovascular space invasion positive women with stage IIIC endometriod endometrial cancer.
    Cuylan ZF; Oz M; Ozkan NT; Comert GK; Sahin H; Turan T; Akbayir O; Kuscu E; Celik H; Dede M; Gungor T; Meydanli MM; Ayhan A
    J Obstet Gynaecol Res; 2018 Jun; 44(6):1140-1149. PubMed ID: 29516573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer].
    Wang Y; Yu M; Yang JX; Cao DY; Zhang Y; Shen K; You Y
    Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):816-822. PubMed ID: 30585019
    [No Abstract]   [Full Text] [Related]  

  • 6. The impact of lymphovascular space invasion on survival in early stage low-grade endometrioid endometrial cancer.
    Yarandi F; Shirali E; Akhavan S; Nili F; Ramhormozian S
    Eur J Med Res; 2023 Mar; 28(1):118. PubMed ID: 36915143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphovascular space invasion (LVSI) is an isolated poor prognostic factor for recurrence and survival among women with intermediate- to high-risk early-stage endometrioid endometrial cancer.
    Weinberg LE; Kunos CA; Zanotti KM
    Int J Gynecol Cancer; 2013 Oct; 23(8):1438-45. PubMed ID: 24257558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is Substantial Lymphovascular Space Invasion Prognostic for Clinical Outcomes in Type II Endometrial Cancer?
    Jaishankar S; Pifer PM; Bhargava R; Keller A; Musunuru HB; Patel AK; Sukumvanich P; Boisen M; Berger JL; Taylor S; Courtney-Brooks M; Olawaiye A; Lesnock J; Edwards R; Vargo JA; Beriwal S
    Clin Oncol (R Coll Radiol); 2022 Jul; 34(7):452-458. PubMed ID: 35264314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective analysis of prognostic variables and clinical outcomes in surgically staged intermediate risk endometrial carcinoma.
    Zhang GY; Wu LY; Li B; Huang MN; Zhang R; Li XG
    Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):309-16. PubMed ID: 23540792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Significance of Lymphovascular Space Invasion in the Absence of Lymph Node Metastases in Early-Stage Endometrial Cancer.
    Cusano E; Myers V; Samant R; Sudai T; Keller A; Le T; E C; Grimes S; Xu Y
    Int J Gynecol Cancer; 2018 Jun; 28(5):890-894. PubMed ID: 29538248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer--A pooled analysis of PORTEC 1 and 2 trials.
    Bosse T; Peters EE; Creutzberg CL; Jürgenliemk-Schulz IM; Jobsen JJ; Mens JW; Lutgens LC; van der Steen-Banasik EM; Smit VT; Nout RA
    Eur J Cancer; 2015 Sep; 51(13):1742-50. PubMed ID: 26049688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors predicting recurrence in patients with stage IA endometrioid endometrial cancer: what is the importance of LVSI?
    Ureyen I; Karalok A; Turkmen O; Kimyon G; Akdas YR; Akyol A; Tasci T; Turan T
    Arch Gynecol Obstet; 2020 Mar; 301(3):737-744. PubMed ID: 31883046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of lymphovascular space invasion in patients with endometrioid endometrial cancer: a retrospective study from a single center.
    Dai Y; Dong Y; Cheng Y; Hou H; Wang J; Wang Z; Wang J
    J Gynecol Oncol; 2020 May; 31(3):e27. PubMed ID: 31912681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-endometrioid endometrial cancer: analysis of recurrence pattern and identification of prognostic and treatment factors affecting recurrence and survival.
    Lee SJ; Kang HJ; Kwak YK; Kim M; Kim J
    Strahlenther Onkol; 2023 Sep; 199(9):828-837. PubMed ID: 36930247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unique prognostic features of grade 3 endometrioid endometrial carcinoma: Findings from 101 consecutive cases at a Japanese tertiary cancer center.
    Kato MK; Yoshida H; Uehara T; Uno M; Ishikawa M; Miyasaka N; Kato T
    Taiwan J Obstet Gynecol; 2021 Mar; 60(2):238-244. PubMed ID: 33678322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphadenectomy in women with endometrial cancer: aspiration and reality from a radiation oncologist's point of view.
    Foerster R; Kluck R; Arians N; Rieken S; Rief H; Adeberg S; Bostel T; Schlampp I; Debus J; Lindel K
    Radiat Oncol; 2015 Jul; 10():147. PubMed ID: 26179059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining prognostic variables in recurrent endometrioid endometrial cancer: a 15-year single-institution review.
    Esselen KM; Boruta DM; del Carmen M; Schorge JO; Goodman A; Growdon WB
    Int J Gynecol Cancer; 2011 Aug; 21(6):1078-83. PubMed ID: 21633304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant Chemotherapy versus Radiotherapy in High-risk, Early-stage Endometrioid Endometrial Carcinoma.
    Wu M; Yang YN; Huang YH; Cai J; He XQ; Wang ZH
    Curr Med Sci; 2022 Feb; 42(1):185-191. PubMed ID: 34669113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of recurrence and survival in lymphovascular space invasion negative early-stage endometrioid endometrial cancer patients.
    Altın D; Akıncı T; Taşkın S; Ortaç F
    J Turk Ger Gynecol Assoc; 2023 Dec; 24(4):261-270. PubMed ID: 38054418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of lymph node ratio on survival in stage IIIC endometrioid endometrial cancer: a Turkish Gynecologic Oncology Group study.
    Ayhan A; Topfedaisi Ozkan N; Öz M; Kimyon Comert G; Firat Cuylan Z; Çoban G; Turkmen O; Erdem B; Şahin H; Akbayır Ö; Dede M; Turan AT; Celik H; Güngör T; Haberal A; Arvas M; Meydanli MM
    J Gynecol Oncol; 2018 Jul; 29(4):e48. PubMed ID: 29770619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.